Richard Bartfai, theme Infectious diseases and global health, and Clemens Kocken (BPRC) received 675,000 euros from ZonMw to uncover the molecular mechanisms underlying dormancy of malaria parasites, a major obstacle to efficient treatment of Plasmodium vivax malaria.Plasmodium vivax causes severe morbidity in Asia and South-America and is regarded as a major challenge to malaria elimination. The biggest obstacle in fighting P. vivax is the presence of dormant parasites. These, so called, hypnozoites can stay dormant in the liver without any symptoms for weeks to years, survive treatment of blood stage infection and reactivate causing malaria without renewed exposure to infected mosquitos. In order to better target hypnozoites, it is important to unravel the mechanisms behind their dormancy and reactivation. Hypnozoites, however, have long been inaccessible for experimental investigations and hence represent a major knowledge gap in our understanding of the parasite’s life cycle, which in turn hinders drug development.
Therefore, in this project, Clemens Kocken and Richard Bartfai will form a powerful partnership to combine state-of-the-art genomic technologies and a unique transgenic model system to understand mechanisms that drive liver stage parasites into dormancy or dictate their reactivation. These insights may prove essential to further vivax malaria control and elimination by paving the way for new and innovative approaches to target this critical human pathogen.
Related news items
ERC Consolidator Grant for Bousema and Sechopoulos12 December 2019
Teun Bousema and Ioannis Sechopoulos are to receive an ERC Consolidator Grant of around two million euros each. This European research subsidy will enable them to carry out research for the next five years.read more
New insights into the initiation of T cell responses in the spleen11 December 2019
Carl Figdor and colleagues, theme Cancer development and immune defense, provide insights into the initiation of T cell responses in the spleen and their consequences for T cell differentiation. They have published their results in Proceedings of the National Academy of Sciences USA.read more
A personal touch of Marieke Willemse10 December 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Marieke Willemse.read more
Two teams of RIMLS-FNWI participate in Alpe d'HuZes10 December 2019
Sixteen employees of the research institute RIMLS-FNWI have taken on the challenge to run, bike or hike up the mountain Alpe d’Huez as many times as possible 4 June 2020, to raise as much money as possible for cancer research.read more
Dietrich-Knorr Prize for Hedi Claahsen-van der Grinten10 December 2019
Hedi Claahsen-van der Grinten, theme Vascular damage, received the Dietrich-Knorr prize 2019 for the best published paper in the field of adrenal research, for her publication in the Journal of Clinical endocrinology & Metabolism.read more
Help wanted to organize the New Frontiers symposium in 20219 December 2019
Are you a 1st or 2nd year PhD candidate with the ambition to organize an international symposium? The organizing committee of the RIMLS New Frontiers Symposium in 2021 dedicated to Glycobiology is looking for two PhD candidates who are interested to participate in the organization.read more